Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.

Slides:



Advertisements
Similar presentations
Farmaci usati prima dellintervento Basi farmacologiche del loro uso La prevenzione del tromboembolismo.
Advertisements

Implementing NICE guidance
Hollie Shaner-McRae DNP RN FAAN
Working together to achieve nursing excellence in VTE Katrina Glaister Clinical Governance Facilitator (VTE Project Nurse) Salisbury NHS Foundation Trust.
Preventing VTE in Surgical Patients. Today’s Topics The common sense science of VTE prevention Brief history of VTE prevention techniques High yield methods.
LHD Logo Venous Thromboembolism Reducing the Risk DATE.
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / BACKGROUND Deep Vein Thrombosis is a common, yet preventable peri-operative complication Highest risk in critical.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Beverley Hunt Simon Noble Hospital Acquired Venous Thromboembolism.
QAH HospitalPortsmouth Hospitals NHS Trust Venous Thromboembolism Patient Safety Study Day Simon Freathy.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2013.
DVT Prophylaxis in Medical Patients Rog Kyle, MD MUSC 6/5/12.
CMS Core Measures Evidence-Based Performance Measurement.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
Venous ThromboEmbolism
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
Peter Davies Senior Pharmacist.  Venous thromboembolic prevention is a DH patient safety priority  NICE clinical guideline venous thromboembolism reducing.
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
DVT Prevention and Anticoagulant Management
VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Qmentum ROPs: Tips and Tools for Implementation in Your Organization Teague Lamarche & Greg Kennedy Canadian Patient Safety Officer Course Ottawa, Ontario.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
DVT & PE: How early can I mobilize a patient ??
Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.
Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Venous Thromboembolism (VTE) Etiology, Prevention, Recognition, and Treatment 1.
Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Prevention of Venous Thromboembolism in Nonsurgical Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Insert name of presentation on Master Slide Hospital Acquired Thrombosis Simon Noble and Mike Fealey.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Prevention of Venous Thromboembolism in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Outpatient DVT assessment & treatment Daniel Gilada.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
VTE prophylaxis Sharif-Kashani,B.MD SBMU Preventing VTE Over 12 million people in the United States are at risk of VTE due to hospitalization for major.
Venous Thromboembolism Prophylaxis for Medical Inpatients
Venous Thromboembolism Prophylaxis (VTE)
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Fig. 2. Comparative efficacy of thromboprophylaxis interventions in the prevention of deep vein thrombosis (DVT). (A) Estimated odds ratios (ORs) and 95%
Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon
Copyright © 2012 American Medical Association. All rights reserved.
Ortho Warfarin Dosing Protocol
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
New Oral Anticoagulants and VTE Management
Don't look now! Risk stratify first
Succinct Review of the New VTE Prevention and Management Guidelines
How I treat cancer-associated venous thromboembolism
Presentation transcript:

Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator

1 What is VTE?  VTE is Venous Thromboembolism  Includes deep vein thrombosis (DVT) and pulmonary embolism (PE)  DVT is a blood clot that forms in the deep vein in the leg  PE is a clot that has broken off and traveled to the lungs DVT +/- PE = VTE

2 Why is VTE Important?  VTE is one of most common and preventable complications of hospitalization  The rate of hospital-acquired VTE is % after general surgery and % after hip surgery if thromboprophylaxis is not used  DVT or PE is associated with increased mortality, increased length of stay  Accreditation Canada has made VTE Prophylaxis a Required Organizational Practice (ROP)

3 How Do We Meet the ROP?  Written thromboprophylaxis policy or guideline  Identify patients at risk for VTE and provide appropriate prophylaxis  Audit compliance and use of thromboprophylaxis  Identify major orthopaedic surgery patients requiring post-discharge prophylaxis and provide to them  Provide information to health professionals and patients about risks and prevention 3

4 VTE Prophylaxis Policy  LHSC assesses all patients for the risk of VTE using the Identification of Patients at Risk for VTE (Appendix A) upon:  admission to hospital  a significant change* in clinical status  any Transition Point in care, including discharge Examples include change in activity status – ambulatory to bedrest; becoming more acutely ill; decrease in bleeding risk. 4

5 Risk Assessment – Appendix A 5

6 Decision Tree for Venous Thromboembolism Prophylaxis (VTE)  Decision tree can be launched from the VTE module and can also be found on the VTE website Decision tree 6

7 Risk Assessment – Who and When  Conducted by the Most Responsible Professional (MRP)/delegate at:  time of admission  discharge.  Conducted by the MRP/delegate OR another member of the health care team (HCT):  throughout hospital admission – transitions in care and changes in clinical status 7

8 Appropriate Prophylaxis  Pharmacological prophylaxis  Low molecular weight heparin (LMWH)  Low dose unfractionated heparin  Other anticoagulant  Mechanical prophylaxis  For patients with high risk of bleeding  Intermittent Pneumatic Compression (IPC) devices with or without Anti-embolic stockings (TEDs) 8

9 Steps for Determining VTE Prophylaxis Venous thromboembolism prophylaxis is a three step process which includes: 1. Determining if VTE prophylaxis is required (guidelines provided in Appendix A). 2. Determining if VTE prophylaxis is contraindicated, considering both pharmacological and mechanical prophylaxis options, where applicable (guidelines provided in Appendix A) 3. Determining and providing the appropriate prophylaxis for eligible patients. (guidelines provided in Appendix B or C) 9

10 How to Order  On admission and at transition points use the VTE Module 10

11 How to Order 11 Risk assessment Appropriate Prophylaxis

12 Patient Education  Important to educate patients on their risk and how to prevent VTE  Pamphlet available and can be accessed through website Pamphlet 12

13 Staff Resources  Website  Staff presentations  Poster Poster 13

14Questions? Mary-Anne Davies – ext or 14